Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Plasminogen | ||
Ligand | BDBM50057826 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_155254 (CHEMBL764407) | ||
Ki | 165000±n/a nM | ||
Citation | Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Baskin, EP; Woltmann, R; Lynch, JJ; Lyle, EA; Appleby, SD; Chen, IW; Dancheck, KB; Vacca, JP Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacy. J Med Chem40:1565-9 (1997) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Plasminogen | |||
Name: | Plasminogen | ||
Synonyms: | Activation peptide | Angiostatin | PLG | PLMN_HUMAN | Plasmin | Plasmin heavy chain A | Plasmin heavy chain A, short form | Plasmin light chain B | ||
Type: | Enzyme | ||
Mol. Mass.: | 90579.18 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 810 | ||
Sequence: |
| ||
BDBM50057826 | |||
n/a | |||
Name | BDBM50057826 | ||
Synonyms: | (S)-1-((R)-2-Amino-3,3-dicyclohexyl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide | 1-(2-Amino-3,3-dicyclohexyl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide | CHEMBL289395 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H48N4O2 | ||
Mol. Mass. | 460.6956 | ||
SMILES | N[C@H](C(C1CCCCC1)C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NCC1CCC(N)CC1 |wU:21.24,wD:1.0,(8.57,-5.29,;9.89,-4.53,;9.89,-2.99,;11.24,-2.22,;12.55,-2.99,;13.9,-2.22,;13.9,-.68,;12.58,.09,;11.23,-.68,;8.57,-2.21,;7.23,-2.98,;5.9,-2.21,;5.9,-.67,;7.23,.1,;8.57,-.67,;11.24,-5.3,;11.24,-6.84,;12.72,-4.89,;13.26,-3.44,;14.8,-3.51,;15.22,-5,;13.92,-5.85,;13.86,-7.39,;12.49,-8.1,;15.15,-8.21,;16.52,-7.51,;17.82,-8.32,;17.78,-9.66,;18.86,-11.05,;17.78,-12.17,;18.86,-13.25,;17.85,-10.92,;16.76,-9.44,)| | ||
Structure |